«When a pharmaceutical company needs to test a new drug, it employs a Contract Research Organisation (CRO). These are companies that specialise in designing clinical trials. But in today’s medical landscape we have a new tool that also needs testing: artificial intelligence (AI). AI in the healthcare market is skyrocketing, growing at a rate of 167.1% from 2019 to 2021. And vast amounts of medical data are needed to train and test all of those algorithms. Obtaining high-quality data can be tricky, creating demand for a ‘CRO-for-AI’.»

«This is the niche that startup Gesund is hoping to fill. Gesund provides AI companies with curated medical data and tools to help them test and refine their algorithms to optimise patient outcomes, and secure regulatory clearance.»

Article written by Matthew Hempstead